Literature DB >> 8453595

DNA amplification in human gastric carcinomas.

O Mor1, G N Ranzani, Y Ravia, G Rotman, M Gutman, A Manor, D Amadori, J Houldsworth, M Hollstein, M Schwab, Y Shiloh.   

Abstract

We recently identified a genomic domain at chromosome 10q26 that is highly amplified in the gastric carcinoma cell lines KATO III and SNU-16 and contains the BEK/K-sam gene, which encodes several growth factor receptors. A contiguous segment of 200 kb spanning this gene was amplified in five of 139 (3.6%) primary gastric carcinomas, all of them classified as poorly differentiated tumors. There was no amplification of this genomic region in a variety of other solid tumors. The overall frequency of gene amplification among the gastric carcinomas rose to 19.4% when MYC, ERBB2, and INT2 were included in the analysis, with significant association with advanced tumor stage. Amplification of various genomic regions in solid tumors may be more frequent than previously estimated.

Entities:  

Mesh:

Year:  1993        PMID: 8453595     DOI: 10.1016/0165-4608(93)90217-a

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  11 in total

1.  siRNA-participated chemotherapy: an efficient and specific therapeutic against gastric cancer.

Authors:  Donglei Zhou; Xun Jiang; Weixing Ding; Lijun Zheng; Lei Yang; Chengzhu Zheng; Liesheng Lu
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-28       Impact factor: 4.553

2.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

3.  FGFR2, HER2 and cMet in gastric adenocarcinoma: detection, prognostic significance and assessment of downstream pathway activation.

Authors:  Guy Betts; Helen Valentine; Sue Pritchard; Richard Swindell; Victoria Williams; Shethah Morgan; Ewen A Griffiths; Ian Welch; Catharine West; Christopher Womack
Journal:  Virchows Arch       Date:  2013-12-04       Impact factor: 4.064

4.  FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study.

Authors:  X Su; P Zhan; P R Gavine; S Morgan; C Womack; X Ni; D Shen; Y-J Bang; S-A Im; W Ho Kim; E-J Jung; H I Grabsch; E Kilgour
Journal:  Br J Cancer       Date:  2014-01-23       Impact factor: 7.640

Review 5.  Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers.

Authors:  Kai Hung Tiong; Li Yen Mah; Chee-Onn Leong
Journal:  Apoptosis       Date:  2013-12       Impact factor: 4.677

6.  Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.

Authors:  Seyoung Seo; Seong Joon Park; Min-Hee Ryu; Sook Ryun Park; Baek-Yeol Ryoo; Young Soo Park; Young-Soon Na; Chae-Won Lee; Ju-Kyung Lee; Yoon-Koo Kang
Journal:  Oncotarget       Date:  2017-05-16

7.  Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targeting gastrointestinal cancers.

Authors:  Aleksandra Borek; Aleksandra Sokolowska-Wedzina; Grzegorz Chodaczek; Jacek Otlewski
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

8.  Intratumor heterogeneity of centromere numerical abnormality in multiple primary gastric cancers: application of fluorescence in situ hybridization with intermittent microwave irradiation on paraffin-embedded tissue.

Authors:  K Kobayashi; Y Kitayama; H Igarashi; G Yoshino; T Kobayashi; T Kazui; H Sugimura
Journal:  Jpn J Cancer Res       Date:  2000-11

9.  Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use.

Authors:  Harshnira Patani; Tom D Bunney; Nethaji Thiyagarajan; Richard A Norman; Derek Ogg; Jason Breed; Paul Ashford; Andrew Potterton; Mina Edwards; Sarah V Williams; Gary S Thomson; Camilla S M Pang; Margaret A Knowles; Alexander L Breeze; Christine Orengo; Chris Phillips; Matilda Katan
Journal:  Oncotarget       Date:  2016-04-26

10.  In situ analysis of FGFR2 mRNA and comparison with FGFR2 gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patients.

Authors:  Yasutoshi Kuboki; Christoph A Schatz; Karl Koechert; Sabine Schubert; Janine Feng; Sabine Wittemer-Rump; Karl Ziegelbauer; Thomas Krahn; Akiko Kawano Nagatsuma; Atsushi Ochiai
Journal:  Gastric Cancer       Date:  2017-08-29       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.